Patents Assigned to R. T. Alamo Ventures I, Inc.
  • Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
    Publication number: 20040191178
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine as a sublingual spray or aerosol, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: February 3, 2004
    Publication date: September 30, 2004
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
    Patent number: 6685951
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine as a sublingual spray or aerosol, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: February 3, 2004
    Assignee: R. T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine
    Publication number: 20030022910
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine across the oral mucosa, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: April 26, 2002
    Publication date: January 30, 2003
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Sublingual administration of dihydroergotamine for the treatment of migraine
    Publication number: 20030017175
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine sublingually, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: March 6, 2002
    Publication date: January 23, 2003
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
    Publication number: 20030017994
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine as a sublingual spray or aerosol, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: April 26, 2002
    Publication date: January 23, 2003
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler